OVERVIEW

HIV and Liver Disease 2021 is organized by University of Cincinnati (UC) Conference & Event Services (CES) and will be held from Sep 09 - 11, 2021 at Snake River Lodge & Spa, Teton Village, Wyoming, United States of America. This Conference is also available as Live Webinar.

Target Audience:
The intended audience will consist of experts in the fields of Infectious Diseases and Hepatology and Liver Transplantation, students, trainees, young investigators, nurse practitioners and other clinicians, and those involved with drug development and approval.

Accreditation:
The University of Cincinnati designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Program Overview:
Liver disease has emerged as a major cause of morbidity and mortality in individuals infected with HIV, including those infected with HBV and HCV. The HIV & Liver Disease 2021 conference is designed to address the increasingly prevalent clinical issues and challenges associated with HIV and liver disease. The conference brings together internationally renowned experts and clinicians from a variety of disciplines, including hepatology and infectious diseases, who will present and discuss the most current and clinically relevant information pertinent to improving patient outcomes.

This activity will address the critical need for cross-disciplinary venues that focus on issues of liver disease in HIV-infected patients. It will bring together a group of national and international thought leaders to present current and relevant data that promotes an understanding of liver disease in patients with HIV infection. It will also provide an educational opportunity for young investigators to interact with leading authorities in the fields of HIV and liver disease in a focused and intimate setting.

Educational Objectives:
After completing this activity, the participant should be better able to:
• Review the epidemiology of HIV infection and liver disease in co-infected patients
• Discuss current treatment guidelines for the management of HIV-infected patients with HBV and HCV
• Explain issues of aging of the liver and other organs in the setting of HIV
• Explain the pathogenesis of liver injury & disease progression in patients infected with HIV
• Describe the effect of alcohol on liver injury and ways to reduce harm from alcohol and other substances
???????• Report on the drugs currently being used and to be used for treatment of viral hepatitis
???????• Analyze the progression of decompensated liver and HCC and the role of liver transplantation in those with HIV and liver disease
???????• Assess the risk of antiretroviral therapy (ART) injury in patients with ESLD
???????• Summarize the psychiatric difficulties that can develop in HIV-infected patients with liver disease
???????• Examine treatment outcomes in injection drug users co-infected with HIV and liver disease
???????• Recognize emerging virus infections including HDV & HEV as well as NAFLD/NASH